nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—ABCB1—Methylprednisolone—psoriatic arthritis	0.107	0.131	CbGbCtD
Loperamide—CYP2B6—Dexamethasone—psoriatic arthritis	0.079	0.0964	CbGbCtD
Loperamide—ABCB1—Betamethasone—psoriatic arthritis	0.0696	0.085	CbGbCtD
Loperamide—ABCB1—Prednisolone—psoriatic arthritis	0.0687	0.0839	CbGbCtD
Loperamide—ABCB1—Prednisone—psoriatic arthritis	0.0649	0.0792	CbGbCtD
Loperamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0642	0.0783	CbGbCtD
Loperamide—CYP2C8—Dexamethasone—psoriatic arthritis	0.0598	0.073	CbGbCtD
Loperamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0486	0.0594	CbGbCtD
Loperamide—CYP3A4—Betamethasone—psoriatic arthritis	0.0417	0.0509	CbGbCtD
Loperamide—CYP3A4—Prednisolone—psoriatic arthritis	0.0412	0.0502	CbGbCtD
Loperamide—ABCB1—Dexamethasone—psoriatic arthritis	0.0405	0.0494	CbGbCtD
Loperamide—CYP3A4—Prednisone—psoriatic arthritis	0.0389	0.0475	CbGbCtD
Loperamide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0382	0.0466	CbGbCtD
Loperamide—ABCB1—Methotrexate—psoriatic arthritis	0.0325	0.0397	CbGbCtD
Loperamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0243	0.0296	CbGbCtD
Loperamide—POMC—vertebral column—psoriatic arthritis	0.0165	0.685	CbGeAlD
Loperamide—Megacolon toxic—Methotrexate—psoriatic arthritis	0.0164	0.104	CcSEcCtD
Loperamide—Megacolon—Methotrexate—psoriatic arthritis	0.0083	0.053	CcSEcCtD
Loperamide—Distention—Prednisone—psoriatic arthritis	0.00692	0.0441	CcSEcCtD
Loperamide—POMC—skin of body—psoriatic arthritis	0.00314	0.13	CbGeAlD
Loperamide—Flatulence—Auranofin—psoriatic arthritis	0.00303	0.0193	CcSEcCtD
Loperamide—Angioedema—Auranofin—psoriatic arthritis	0.00281	0.0179	CcSEcCtD
Loperamide—Dyspepsia—Auranofin—psoriatic arthritis	0.00221	0.0141	CcSEcCtD
Loperamide—Constipation—Auranofin—psoriatic arthritis	0.00215	0.0137	CcSEcCtD
Loperamide—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00205	0.0131	CcSEcCtD
Loperamide—Urticaria—Auranofin—psoriatic arthritis	0.002	0.0127	CcSEcCtD
Loperamide—Abdominal pain—Auranofin—psoriatic arthritis	0.00199	0.0127	CcSEcCtD
Loperamide—Pruritus—Auranofin—psoriatic arthritis	0.00178	0.0113	CcSEcCtD
Loperamide—Diarrhoea—Auranofin—psoriatic arthritis	0.00172	0.011	CcSEcCtD
Loperamide—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.0017	0.0109	CcSEcCtD
Loperamide—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.00168	0.0107	CcSEcCtD
Loperamide—Vomiting—Auranofin—psoriatic arthritis	0.0016	0.0102	CcSEcCtD
Loperamide—Rash—Auranofin—psoriatic arthritis	0.00158	0.0101	CcSEcCtD
Loperamide—Dermatitis—Auranofin—psoriatic arthritis	0.00158	0.0101	CcSEcCtD
Loperamide—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.00157	0.01	CcSEcCtD
Loperamide—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00155	0.00987	CcSEcCtD
Loperamide—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00154	0.00985	CcSEcCtD
Loperamide—Nausea—Auranofin—psoriatic arthritis	0.00149	0.00951	CcSEcCtD
Loperamide—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00142	0.00907	CcSEcCtD
Loperamide—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00142	0.00907	CcSEcCtD
Loperamide—Abdominal distension—Prednisolone—psoriatic arthritis	0.00142	0.00904	CcSEcCtD
Loperamide—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.0014	0.00896	CcSEcCtD
Loperamide—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.0014	0.00896	CcSEcCtD
Loperamide—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.00132	0.00839	CcSEcCtD
Loperamide—Abdominal distension—Triamcinolone—psoriatic arthritis	0.0013	0.00831	CcSEcCtD
Loperamide—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.0013	0.00829	CcSEcCtD
Loperamide—Abdominal distension—Prednisone—psoriatic arthritis	0.00103	0.00657	CcSEcCtD
Loperamide—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00102	0.00652	CcSEcCtD
Loperamide—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000934	0.00596	CcSEcCtD
Loperamide—Angioedema—Prednisolone—psoriatic arthritis	0.000897	0.00572	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000891	0.00568	CcSEcCtD
Loperamide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000862	0.0055	CcSEcCtD
Loperamide—CALM2—skin of body—psoriatic arthritis	0.000856	0.0355	CbGeAlD
Loperamide—CALM1—skin of body—psoriatic arthritis	0.000853	0.0354	CbGeAlD
Loperamide—CALM3—tendon—psoriatic arthritis	0.00083	0.0344	CbGeAlD
Loperamide—Discomfort—Prednisolone—psoriatic arthritis	0.000825	0.00526	CcSEcCtD
Loperamide—Angioedema—Triamcinolone—psoriatic arthritis	0.000824	0.00526	CcSEcCtD
Loperamide—Angioedema—Methylprednisolone—psoriatic arthritis	0.000823	0.00525	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000801	0.00511	CcSEcCtD
Loperamide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000793	0.00506	CcSEcCtD
Loperamide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000791	0.00505	CcSEcCtD
Loperamide—Drowsiness—Methotrexate—psoriatic arthritis	0.000763	0.00486	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000761	0.00485	CcSEcCtD
Loperamide—Discomfort—Triamcinolone—psoriatic arthritis	0.000759	0.00484	CcSEcCtD
Loperamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000757	0.00483	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000756	0.00482	CcSEcCtD
Loperamide—Dry mouth—Triamcinolone—psoriatic arthritis	0.000751	0.00479	CcSEcCtD
Loperamide—Angioedema—Dexamethasone—psoriatic arthritis	0.000748	0.00477	CcSEcCtD
Loperamide—Angioedema—Betamethasone—psoriatic arthritis	0.000748	0.00477	CcSEcCtD
Loperamide—Immune system disorder—Prednisone—psoriatic arthritis	0.00074	0.00472	CcSEcCtD
Loperamide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000736	0.0047	CcSEcCtD
Loperamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000735	0.00469	CcSEcCtD
Loperamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000721	0.00459	CcSEcCtD
Loperamide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00072	0.00459	CcSEcCtD
Loperamide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00072	0.00459	CcSEcCtD
Loperamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000714	0.00455	CcSEcCtD
Loperamide—Discomfort—Dexamethasone—psoriatic arthritis	0.000689	0.00439	CcSEcCtD
Loperamide—Discomfort—Betamethasone—psoriatic arthritis	0.000689	0.00439	CcSEcCtD
Loperamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000676	0.00431	CcSEcCtD
Loperamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000671	0.00428	CcSEcCtD
Loperamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000668	0.00426	CcSEcCtD
Loperamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000668	0.00426	CcSEcCtD
Loperamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000655	0.00418	CcSEcCtD
Loperamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000655	0.00418	CcSEcCtD
Loperamide—CALM2—tendon—psoriatic arthritis	0.000652	0.027	CbGeAlD
Loperamide—Angioedema—Prednisone—psoriatic arthritis	0.000652	0.00415	CcSEcCtD
Loperamide—CALM1—tendon—psoriatic arthritis	0.000649	0.0269	CbGeAlD
Loperamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000648	0.00413	CcSEcCtD
Loperamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000647	0.00413	CcSEcCtD
Loperamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000647	0.00412	CcSEcCtD
Loperamide—CYP2B6—skin of body—psoriatic arthritis	0.000637	0.0264	CbGeAlD
Loperamide—Urticaria—Prednisolone—psoriatic arthritis	0.000636	0.00406	CcSEcCtD
Loperamide—Fatigue—Triamcinolone—psoriatic arthritis	0.000635	0.00405	CcSEcCtD
Loperamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000633	0.00404	CcSEcCtD
Loperamide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000627	0.004	CcSEcCtD
Loperamide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000618	0.00394	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000603	0.00384	CcSEcCtD
Loperamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000601	0.00383	CcSEcCtD
Loperamide—Discomfort—Prednisone—psoriatic arthritis	0.0006	0.00382	CcSEcCtD
Loperamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00059	0.00376	CcSEcCtD
Loperamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000588	0.00375	CcSEcCtD
Loperamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000588	0.00375	CcSEcCtD
Loperamide—Urticaria—Triamcinolone—psoriatic arthritis	0.000585	0.00373	CcSEcCtD
Loperamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000584	0.00372	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000582	0.00371	CcSEcCtD
Loperamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000581	0.0037	CcSEcCtD
Loperamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000577	0.00368	CcSEcCtD
Loperamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000577	0.00368	CcSEcCtD
Loperamide—Fatigue—Betamethasone—psoriatic arthritis	0.000576	0.00367	CcSEcCtD
Loperamide—Fatigue—Dexamethasone—psoriatic arthritis	0.000576	0.00367	CcSEcCtD
Loperamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000571	0.00364	CcSEcCtD
Loperamide—Skin disorder—Prednisone—psoriatic arthritis	0.000565	0.0036	CcSEcCtD
Loperamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000546	0.00348	CcSEcCtD
Loperamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000546	0.00348	CcSEcCtD
Loperamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000543	0.00346	CcSEcCtD
Loperamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000541	0.00345	CcSEcCtD
Loperamide—Urticaria—Betamethasone—psoriatic arthritis	0.000531	0.00338	CcSEcCtD
Loperamide—Urticaria—Dexamethasone—psoriatic arthritis	0.000531	0.00338	CcSEcCtD
Loperamide—Dizziness—Prednisolone—psoriatic arthritis	0.00053	0.00338	CcSEcCtD
Loperamide—Asthenia—Triamcinolone—psoriatic arthritis	0.000528	0.00337	CcSEcCtD
Loperamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000528	0.00337	CcSEcCtD
Loperamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000528	0.00337	CcSEcCtD
Loperamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000527	0.00336	CcSEcCtD
Loperamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000521	0.00332	CcSEcCtD
Loperamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00052	0.00331	CcSEcCtD
Loperamide—Dyspepsia—Prednisone—psoriatic arthritis	0.000512	0.00327	CcSEcCtD
Loperamide—Rash—Prednisolone—psoriatic arthritis	0.000505	0.00322	CcSEcCtD
Loperamide—Dermatitis—Prednisolone—psoriatic arthritis	0.000504	0.00322	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000504	0.00321	CcSEcCtD
Loperamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000503	0.00321	CcSEcCtD
Loperamide—Fatigue—Prednisone—psoriatic arthritis	0.000502	0.0032	CcSEcCtD
Loperamide—Headache—Prednisolone—psoriatic arthritis	0.000502	0.0032	CcSEcCtD
Loperamide—Discomfort—Methotrexate—psoriatic arthritis	0.000501	0.0032	CcSEcCtD
Loperamide—Constipation—Prednisone—psoriatic arthritis	0.000498	0.00317	CcSEcCtD
Loperamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000487	0.00311	CcSEcCtD
Loperamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000486	0.0031	CcSEcCtD
Loperamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000486	0.0031	CcSEcCtD
Loperamide—Asthenia—Betamethasone—psoriatic arthritis	0.000479	0.00306	CcSEcCtD
Loperamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000479	0.00306	CcSEcCtD
Loperamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000477	0.00304	CcSEcCtD
Loperamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000476	0.00303	CcSEcCtD
Loperamide—Nausea—Prednisolone—psoriatic arthritis	0.000476	0.00303	CcSEcCtD
Loperamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000473	0.00301	CcSEcCtD
Loperamide—Pruritus—Betamethasone—psoriatic arthritis	0.000473	0.00301	CcSEcCtD
Loperamide—Skin disorder—Methotrexate—psoriatic arthritis	0.000472	0.00301	CcSEcCtD
Loperamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000468	0.00299	CcSEcCtD
Loperamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000467	0.00298	CcSEcCtD
Loperamide—Rash—Triamcinolone—psoriatic arthritis	0.000464	0.00296	CcSEcCtD
Loperamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000464	0.00296	CcSEcCtD
Loperamide—Rash—Methylprednisolone—psoriatic arthritis	0.000463	0.00295	CcSEcCtD
Loperamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000463	0.00295	CcSEcCtD
Loperamide—Urticaria—Prednisone—psoriatic arthritis	0.000462	0.00295	CcSEcCtD
Loperamide—Headache—Triamcinolone—psoriatic arthritis	0.000461	0.00294	CcSEcCtD
Loperamide—Headache—Methylprednisolone—psoriatic arthritis	0.00046	0.00294	CcSEcCtD
Loperamide—Abdominal pain—Prednisone—psoriatic arthritis	0.00046	0.00293	CcSEcCtD
Loperamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000457	0.00292	CcSEcCtD
Loperamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000457	0.00292	CcSEcCtD
Loperamide—Dizziness—Betamethasone—psoriatic arthritis	0.000442	0.00282	CcSEcCtD
Loperamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000442	0.00282	CcSEcCtD
Loperamide—Nausea—Triamcinolone—psoriatic arthritis	0.000437	0.00279	CcSEcCtD
Loperamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000436	0.00278	CcSEcCtD
Loperamide—Somnolence—Methotrexate—psoriatic arthritis	0.000432	0.00276	CcSEcCtD
Loperamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000429	0.00273	CcSEcCtD
Loperamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000428	0.00273	CcSEcCtD
Loperamide—Vomiting—Betamethasone—psoriatic arthritis	0.000425	0.00271	CcSEcCtD
Loperamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000425	0.00271	CcSEcCtD
Loperamide—Rash—Dexamethasone—psoriatic arthritis	0.000421	0.00269	CcSEcCtD
Loperamide—Rash—Betamethasone—psoriatic arthritis	0.000421	0.00269	CcSEcCtD
Loperamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000421	0.00268	CcSEcCtD
Loperamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000421	0.00268	CcSEcCtD
Loperamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00042	0.00268	CcSEcCtD
Loperamide—Fatigue—Methotrexate—psoriatic arthritis	0.000419	0.00267	CcSEcCtD
Loperamide—Headache—Betamethasone—psoriatic arthritis	0.000419	0.00267	CcSEcCtD
Loperamide—Headache—Dexamethasone—psoriatic arthritis	0.000419	0.00267	CcSEcCtD
Loperamide—Asthenia—Prednisone—psoriatic arthritis	0.000418	0.00266	CcSEcCtD
Loperamide—Pruritus—Prednisone—psoriatic arthritis	0.000412	0.00263	CcSEcCtD
Loperamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000398	0.00254	CcSEcCtD
Loperamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000398	0.00254	CcSEcCtD
Loperamide—Nausea—Dexamethasone—psoriatic arthritis	0.000397	0.00253	CcSEcCtD
Loperamide—Nausea—Betamethasone—psoriatic arthritis	0.000397	0.00253	CcSEcCtD
Loperamide—Urticaria—Methotrexate—psoriatic arthritis	0.000386	0.00246	CcSEcCtD
Loperamide—Dizziness—Prednisone—psoriatic arthritis	0.000385	0.00245	CcSEcCtD
Loperamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000384	0.00245	CcSEcCtD
Loperamide—Vomiting—Prednisone—psoriatic arthritis	0.00037	0.00236	CcSEcCtD
Loperamide—Rash—Prednisone—psoriatic arthritis	0.000367	0.00234	CcSEcCtD
Loperamide—Dermatitis—Prednisone—psoriatic arthritis	0.000367	0.00234	CcSEcCtD
Loperamide—Headache—Prednisone—psoriatic arthritis	0.000365	0.00232	CcSEcCtD
Loperamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000358	0.00228	CcSEcCtD
Loperamide—Asthenia—Methotrexate—psoriatic arthritis	0.000349	0.00223	CcSEcCtD
Loperamide—Nausea—Prednisone—psoriatic arthritis	0.000346	0.0022	CcSEcCtD
Loperamide—Pruritus—Methotrexate—psoriatic arthritis	0.000344	0.00219	CcSEcCtD
Loperamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000333	0.00212	CcSEcCtD
Loperamide—Dizziness—Methotrexate—psoriatic arthritis	0.000322	0.00205	CcSEcCtD
Loperamide—Vomiting—Methotrexate—psoriatic arthritis	0.000309	0.00197	CcSEcCtD
Loperamide—Rash—Methotrexate—psoriatic arthritis	0.000307	0.00196	CcSEcCtD
Loperamide—Dermatitis—Methotrexate—psoriatic arthritis	0.000306	0.00195	CcSEcCtD
Loperamide—Headache—Methotrexate—psoriatic arthritis	0.000305	0.00194	CcSEcCtD
Loperamide—Nausea—Methotrexate—psoriatic arthritis	0.000289	0.00184	CcSEcCtD
